Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study to Determine the Safety and Efficacy of SHJ002 Sterile Ophthalmic Solution on Myopia Control in Subjects Aged 3-12 Years.

NCT06579287 is registered in ClinicalTrials.gov with Sunhawk Vision Biotech, Inc. as lead sponsor.

NCT NCT06579287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06579287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study to Determine the Safety and Efficacy of SHJ002 Sterile Ophthalmic Solution on Myopia Control in Subjects Aged 3-12 Years.
Lead sponsor
Sunhawk Vision Biotech, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 22, 2025
Completion date
December 31, 2026
Enrollment
140 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

myopia, progressive